Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZ439 for gametocyte clearance and transmission blocking in malaria
NCT02431650Phase 2Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Apr 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artefenomel in malaria, sponsored by Medicines for Malaria Venture. Started Apr 2015; status: completed.
02
Drugs
artefenomel
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02431650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431650.